Bayer Aktiengesellschaft (ETR:BAYN)
Germany
· Delayed Price · Currency is EUR | Market Cap | 22.27B |
| Revenue (ttm) | 46.61B |
| Net Income (ttm) | -2.55B |
| Shares Out | 982.42M |
| EPS (ttm) | -2.60 |
| PE Ratio | n/a |
| Forward PE | 4.98 |
| Dividend | 0.11 (0.49%) |
| Ex-Dividend Date | Apr 28, 2025 |
| Volume | 2,589,394 |
| Average Volume | 5,281,479 |
| Open | 22.60 |
| Previous Close | 22.67 |
| Day's Range | 22.57 - 23.04 |
| 52-Week Range | 18.41 - 31.03 |
| Beta | 1.04 |
| RSI | 46.60 |
| Earnings Date | Mar 5, 2025 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skinca... [Read more]
Financial Performance
In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.
Financial StatementsNews
Elliott held talks with private equity as it considered new Bayer campaign
US hedge fund gauged investor interest in German conglomerate’s consumer health business
Bayer in licenses Puhe BioPharma’s cancer candidate
Bayer acquires rights in Puhe BioPharma cancer drug candidate
Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with China's Puhe BioPharma.
ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that data from 13 new analyses from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the American Coll...
Bayer told to pay almost $2.1bn over Roundup cancer link claim
A jury in the US state of Georgia has ordered Monsanto parent Bayer to pay nearly $2.1bn (1.94bn) in damages to a man who says the companys Roundup weed killer caused his cancer, according to attorney...
Monsanto parent ordered to pay $2B in Roundup lawsuit damages
The company behind Roundup weedkiller herbicide was ordered to pay more than $2 billion in a man’s cancer lawsuit. According to his attorneys, John Barnes developed non-Hodgkin’s lymphoma after using ...
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2188635534-2cd8b4b5697e42f58f858d2c64bafe8f.jpg)
Bayer Stock Slumps After Firm Ordered To Pay More Than $2B in Latest Roundup Case
Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged cancer risk tied to its Roundup weed killer.
Push-pull over glyphosate in Germany
Bayer is confident it can "restore" the authorisation of the controversial weedkiller.
Bayer ordered to pay €1.9 billion by US court in Roundup cancer case
Pharmaceutical company Bayer took over weed killer Roundup in its acquisition of US agrochemical company Monsanto back in 2018. However, it has since been hit with thousands of cancer-related Roundup ...
Dr. Mike Graham Appointed as New Head of R&D for Bayer’s Crop Science Division
Effective April 15, 2025, he will succeed Dr. Robert Reiter who has decided to retire after 27 years with the company and 34 years in the industry Dr. Mike Graham has profound expertise in R&D and agr...
Dr. Mike Graham Appointed as New Head of R&D for Bayer's Crop Science Division
MONHEIM, Germany--(BUSINESS WIRE)--Bayer announced today that Dr. Mike Graham will become the new Head of Research & Development (R&D) for Bayer's Crop Science division and serve as member of the Lead...
Georgia jury orders Bayer to pay over $2 billion in Monsanto Roundup weedkiller lawsuit over cancer case
The verdict marks the latest in a long-running series of court battles Monsanto has faced over its Roundup herbicide.
Stocks to Watch Monday: Tesla, Bayer, AZEK
Bayer Shares Plunge After U.S. Court Defeat in Roundup Case
Bayer said it was ordered to pay $2.1 billion in a case about its Roundup weedkiller after a jury in a Georgia state court reached a verdict in favor of the plaintiff.
Bayer Shares Plunge After U.S. Court Defeat in Roundup Case
Bayer said it was ordered to pay $2.1 billion in a case about its Roundup weedkiller after a jury in a Georgia state court reached a verdict in favor of the plaintiff.
Man who claimed Roundup weedkiller gave him cancer wins $2.1bn compensation
Pharma and biotech giant Bayer has been ordered to pay $2.1 billion to a man who claimed the company's Roundup weedkiller caused his cancer.
Ga. jurors award $2.1 billion verdict against Bayer in Roundup lawsuit
The jury called for $2 billion in punitive damages, but previous multibillion-dollar verdicts over Roundup were drastically reduced on appeal.
Bayer hit with $2bn Roundup verdict
A jury in the US state of Georgia has ordered the multinational chemical company Bayer to pay $2.1 billion to a plaintiff who claimed its Roundup weed killer caused his cancer, the plaintiff’s law fir...
Bayer hit with $2 billion Roundup verdict in US state of Georgia cancer case
Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms said late o...
U.S. jury orders Bayer to pay $2.1B in Roundup cancer case
Bayer faces a $2.1B jury verdict over Roundup cancer claims, adding to its $10B legal woes. Read more on the case's impact and the company's next steps.
Litigation, Debt, And Decline - Yet Bayer Seems Like A Buy
German Parliament Backs Changes to Constitutional 'Debt Brake'
Germany's parliament backed on Tuesday a plan to increase government borrowing limits as the largest economy in Europe looks to bolster its defense and infrastructure spending. The Bundestag approved ...
Widely used drugs on US imports list from Europe
Widely used prescription medicines could get caught up in the Trump administration's tariff trade wars and EU retaliation.
Bayer Selects Northern Trust as Provider for Digital Lifecycle Management of Carbon Credits
Northern Trust (Nasdaq: NTRS) announced today that it has been selected by Bayer to act as one of its providers for the digital lifecycle management of the Bayer Carbon Program, the company’s voluntar...
Bayer welcomes new law in U.S. state to better shield it against glyphosate litigation
Bayer said on Monday that it welcomed a new law about to be passed in the U.S. state of Georgia to better protect the maker of crop protection chemicals against glyphosate litigation.